Ilns got what they needed out of chain he hasn't come up with anything new since he left now he will have to count solely on his chf compound and ride the tail coat of his work that belongs to ilns
I think ILNS will gain serious traction and see additional investment money pour in when Shire publishes results and migrates to Phase 2 as investors anticipate an ILNS buyout as soon as this year if not next. Also may depend on what Maza will do next with Tau. If he partners Tau with a major pharma and receives a beefy payment, he will most likely add to staff (scientist, cute secretary etc etc) and ILNS will see over a $1 in the near future. We haven't even discussed Conjumab. You are correct. Chain is not the only scientist out there with the expertise we are looking for. Maza would score a serious coup if he brought on a scientist that is well known and highly respected by the street (financial sector) and science community.
I wonder if he has approached Dr. Philip Frost as a minor investor?
News 
Market Data 
Discover 
